CoChat

Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: The aim of the study is to describe the time trend of type 2 diabetes incidence in the largest state of Germany, Bavaria, from 2012 to 2021, and to compare the incidence rates during the pandemic period (2020-2021) to the pre-pandemic period (2012-2019). METHODS: This secondary data analysis uses health claims data provided by the Bavarian Association of Statutory Health Insurance Physicians (KVB), covering approximately 11 million insurees, accounting for 85% of the total population of Bavaria, Germany. Newly diagnosed type 2 diabetes cases in adults (≥20 years) coded as E11 (Diabetes mellitus, Type 2) or E14 (Unspecified diabetes mellitus) under ICD-10, German modification (ICD-10-GM) for the study period 2012 to 2021 were included. Annual and quarterly age-standardised incidence rates (ASIR) stratified by sex, age and region were calculated using the European standard population. Sex-specific crude incidence rates (CIR) were calculated using 10-year age groups. Regression analyses adjusted for time trends, seasonal effects, and pandemic effects were used to analyse the incidence trend and to assess the effect of the pandemic. RESULTS: Overall, 745,861 new cases of type 2 diabetes were diagnosed between 2012 and 2021: 50.4% (376,193 cases) in women. The male/female ratio remained stable over the observation period, while the median age at diagnosis decreased from 61 to 58 years in men and from 66 years to 61 years in women. ASIR were consistently higher for men compared with women, with the yearly difference remaining stable over time (2012: 18%; 2021: 20%). An overall decreasing trend in ASIR was observed during the study period, with a strong decrease from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021 for both sexes. For men, ASIR decreased from 1514 per 100,000 person-years in 2012 to 995 per 100,000 person-years in 2021 (4.6% average annual reduction), and for women from 1238 per 100,000 person-years in 2012 to 796 per 100,000 person-years in 2021 (4.8% average annual reduction). This downward trend was also observed for age groups above 50 years. Regression analyses showed no significant change in incidence rates during the pandemic period (2020 and 2021) compared with the pre-pandemic period. CONCLUSIONS/INTERPRETATION: For the first time, a 10-year incidence trend of type 2 diabetes is reported for Germany, showing a strong decline from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021. The incidence trend of type 2 diabetes appears not to have been affected by the first 2 years of the COVID-19 pandemic. Despite an overall increasing prevalence, the incidence is decreasing, potentially resulting from robust screening by family physicians, reducing the median age at diagnosis by 3 to 5 years. However, further investigation is needed to fully identify the reasons for the declining incidence trend. Continued incidence monitoring is necessary to identify the long-term trend and the potential effect of the pandemic on diagnoses of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-024-06113-8

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Trends of quarterly ASIR of type 2 diabetes from 2012 to 2021 stratified by sex. Grey shaded area, pandemic period; dotted grey line, yearly ASIR
Fig. 1 Trends of quarterly ASIR of type 2 diabetes from 2012 to 2021 stratified by sex. Grey shaded area, pandemic period; dotted grey line, yearly ASIRCC BY · PubMed Central
Fig. 2 Trends of yearly sex- and age-stratified CIR of type 2 diabetes incidence from 2012 to 2021. Grey shaded area, pandemic period; dotted black line, yearly ASIR
Fig. 2 Trends of yearly sex- and age-stratified CIR of type 2 diabetes incidence from 2012 to 2021. Grey shaded area, pandemic period; dotted black line, yearly ASIRCC BY · PubMed Central
Fig. 3 Prediction of type 2 diabetes ASIR from 2012 to 2021 for men. Black dotted line, full Model 1 adjusted for time trend, pandemic effect and seasonal effects; blue dotted line, counterfactual prediction based on Model 3 adjusted for time trend using data from 2012 to 2019; red dotted line, Model 2 adjusted for time trend and pandemic effect but without seasonal effects
Fig. 3 Prediction of type 2 diabetes ASIR from 2012 to 2021 for men. Black dotted line, full Model 1 adjusted for time trend, pandemic effect and seasonal effects; blue dotted line, counterfactual prediction based on Model 3 adjusted for time trend using data from 2012 to 2019; red dotted line, Model 2 adjusted for time trend and pandemic effect but without seasonal effectsCC BY · PubMed Central
Fig. 4 Prediction of type 2 diabetes ASIR from 2012 to 2021 for women. Black dotted line, full Model 1 adjusted for time trend, pandemic effect and seasonal effects; blue dotted line, counterfactual prediction based on Model 3 adjusted for time trend using data from 2012 to 2019; red dotted line, Model 2 adjusted for time trend and pandemic effect but without seasonal effects
Fig. 4 Prediction of type 2 diabetes ASIR from 2012 to 2021 for women. Black dotted line, full Model 1 adjusted for time trend, pandemic effect and seasonal effects; blue dotted line, counterfactual prediction based on Model 3 adjusted for time trend using data from 2012 to 2019; red dotted line, Model 2 adjusted for time trend and pandemic effect but without seasonal effectsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 2

  1. International Diabetes Federation (2021) IDF Diabetes Atlas, 10th edn. International Diabetes Federation, Brussels, Belgium
  2. Pace M, Lanzieri G, Glickman M et al (2013) Revision of the European standard population. Eurostat Methodologies and Working Papers. 10.2785/11470 · doi:10.2785/11470

Cited by

See all 18

Metadata

Authors
Lehner, C. T., Eberl, M., Donnachie, E., Tanaka, L. F., Schauberger, G., Schederecker, F., Himmler, S., Sundmacher, L., & Klug, S. J.
Affiliations
Technical University of Munich (DE)
Corresponding author
Klug, Stefanie J.
Venue
Diabetologia
Published
2024-02-26
Volume
67
Issue
6
Pages
1040-1050
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W4392159140
Cited by
18
References
44
Citations by year
2026: 8 · 2025: 6 · 2024: 4
FWCI
5.93
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (458556631)
  • Technische Universität München
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, incidence trends, COVID-19 pandemic, sex differences, age at diagnosis, Bavaria, statutory health insurance claims, age-standardized incidence rate, sex ratio, seasonal variation, regional variation, health insurance claims data, underdiagnosis in women
MeSH terms
COVID-19, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Female, Germany, Humans, Insurance, Health, Male, Middle Aged, Incidence, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.